JOHNSON & JOHNSON — Director's Dealing 2024

Oct 31, 2024

SEC Form 4/A — Form 4/A

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2024-05-01

Reporting Person: REED JOHN C (EVP, Innovative Medicine, R&D)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-05-01	Common Stock	M	25255	—	Acquired	25561	Direct
2024-05-01	Common Stock	F	10984	$144.59	Disposed	14577	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-05-01	Restricted Share Units	$	M	25255	Disposed		Common Stock (25255)	Direct

Footnotes

F1: The Restricted Share Units awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

F2: Shares withheld for payment of taxes upon vesting of Restricted Share Units.